In addition to the three clinicopathological parameters age, FIGO stage and residual tumor with a statistically significant negative impact on OS, SLCO5A1 was the only independent single gene with a significant positive impact on OS [HR, 0.44 (CI 0.27–0.73) and 0.68 (0.49–0.93) for _2K and the continuous variable, respectively; p = 0.0031; Wald test with two degrees of freedom]. This evidence concerns the gene SLCO5A1 and neoplasm.